Shahid Beheshti University of Medical Sciences University
Recent work (1): An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial (DIC). Recent work (2): Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection (COVID-19)
Technology:
COVID Labs/Universities
Industry:
COVID R&D
Headquarters:
Iran
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership